Earable Neuroscience, founded after nine years of R&D at the University of Colorado and the University of Oxford, aims to unlock human potential through improved sleep and cognitive function. The company’s flagship product, the FRENZ Brainband, is an AI-powered wearable designed to track and stimulate brain activity in real time using personalized audio. This innovative device, paired with the FRENZ mobile app, offers real-time sleep scoring and delivers Cognitive Behavioral Therapy (CBT) audio sessions via bone conduction, catering to all adult head sizes and sleep positions.
Notable investors in Earable Neuroscience include FoundersFund and Samsung Ventures. The company has garnered global recognition for its pioneering technology, which has been featured by major media outlets like BBC News. The FRENZ Brainband has made significant strides in the consumer wearables market, demonstrating a tangible impact on users' sleep quality and cognitive functions. Earable's contributions are setting new standards in the intersection of neuroscience and consumer technology.
